Skip to main content

Table 3 Biological sampling plan

From: A French multicentric prospective prognostic cohort with epidemiological, clinical, biological and treatment information to improve knowledge on lymphoma patients: study protocol of the “REal world dAta in LYmphoma and survival in adults” (REALYSA) cohort

Sampling

Banking constitutional DNA

Banking plasma

Banking serum

NPM-ALKb (ALK+ ALCL)c

Anti-ALK Abd (ALK+ ALCL)

Baselinea

x

x

x

x

x

Day 1 Cycle 3

 

x

 

x

 

End of first-line treatment

 

x

 

x

x

First relapse

 

x

 

x

 
  1. abefore any treatment
  2. bNPM Nucleophosmine
  3. cALK+ ALCL anaplastic lymphoma kinase positive anaplastic large cell lymphoma
  4. dAb Antibodies